| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1c89ce4d9ac03f9acd8ddede1162f94d |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D263-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C41-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C41-18 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C41-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D263-20 |
| filingDate |
2012-10-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8ab0b6f5f2b78c7413d6f693e22c3827
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5bf3bce12975fe4e14b696fe35c9ef1c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1be089253ea55e43d61769c518981e60
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ccb4d668ab71a700eb3e21b753974fc8 |
| publicationDate |
2014-10-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2014303380-A1 |
| titleOfInvention |
Process for a CETP Inhibitor |
| abstract |
An efficient process is disclosed for producing the compound of formula I, which is the CETP inhibitor anacetrapib, which raises HDL-cholesterol and reduces LDL-cholesterol in human patients and may be effective for treating or reducing the risk of developing atherosclerosis: |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112961059-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109384807-A |
| priorityDate |
2011-10-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |